Show simple item record

dc.contributor.authorYoulden, D
dc.contributor.authorBaade, P
dc.contributor.authorAitken, J
dc.contributor.authorGreen, Adèle C
dc.contributor.authorKhosrotehrani, K
dc.date.accessioned2017-09-08T15:01:06Z
dc.date.available2017-09-08T15:01:06Z
dc.date.issued2017-08-03
dc.identifier.citationPrognostic importance of a second invasive primary melanoma according to tumor stage. 2017 Br. J. Dermatol.en
dc.identifier.issn1365-2133
dc.identifier.pmid28771669
dc.identifier.doi10.1111/bjd.15863
dc.identifier.urihttp://hdl.handle.net/10541/620555
dc.description.abstractIt is well known that a considerable proportion of the Caucasian population in many countries are diagnosed with multiple melanomas over time(1) . Despite this, most analyses of melanoma survival, including that of the American Joint Committee on Cancer (AJCC), consider only one tumor for every patient and disregard the potential effect of multiple melanomas on outcomes and this is reflected in the lack of specific management guidelines for patients with multiple melanomas beyond those dictated by the clinicopathological features of each tumour(2-4) . Recently we and others have shown that patients with multiple primary invasive melanomas have an increased risk of melanoma death compared to patients with a single melanoma(5,6) . This article is protected by copyright. All rights reserved.
dc.language.isoenen
dc.rightsArchived with thanks to The British journal of dermatologyen
dc.titlePrognostic importance of a second invasive primary melanoma according to tumor stage.en
dc.typeArticleen
dc.contributor.departmentCancer Council Queensland, Brisbane, Queensland, Australiaen
dc.identifier.journalThe British Journal of Dermatologyen
html.description.abstractIt is well known that a considerable proportion of the Caucasian population in many countries are diagnosed with multiple melanomas over time(1) . Despite this, most analyses of melanoma survival, including that of the American Joint Committee on Cancer (AJCC), consider only one tumor for every patient and disregard the potential effect of multiple melanomas on outcomes and this is reflected in the lack of specific management guidelines for patients with multiple melanomas beyond those dictated by the clinicopathological features of each tumour(2-4) . Recently we and others have shown that patients with multiple primary invasive melanomas have an increased risk of melanoma death compared to patients with a single melanoma(5,6) . This article is protected by copyright. All rights reserved.


This item appears in the following Collection(s)

Show simple item record